Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
37.82
-1.54 (-3.91%)
Nov 15, 2024, 4:00 PM EST - Market closed
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ACHC stock have an average target of 84.75, with a low estimate of 70 and a high estimate of 94. The average target predicts an increase of 124.09% from the current stock price of 37.82.
Analyst Consensus: Buy
* Price targets were last updated on Oct 4, 2024.
Analyst Ratings
The average analyst rating for ACHC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $90 | Hold | Reiterates | $90 | +137.97% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $90 | Hold | Reiterates | $90 | +137.97% | Oct 1, 2024 |
| Barclays | Barclays | Buy Maintains $83 → $76 | Buy | Maintains | $83 → $76 | +100.95% | Sep 30, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $94 | Buy | Reiterates | $94 | +148.55% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
3.23B
from 2.93B
Increased by 10.29%
Revenue Next Year
3.53B
from 3.23B
Increased by 9.23%
EPS This Year
3.49
from -0.24
EPS Next Year
3.74
from 3.49
Increased by 7.41%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.4B | 3.7B | 4.1B | |
| Avg | 3.2B | 3.5B | 3.9B | |
| Low | 3.1B | 3.3B | 3.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 15.0% | 14.8% | 16.5% | |
| Avg | 10.3% | 9.2% | 9.8% | |
| Low | 5.6% | 1.9% | 3.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.73 | 4.40 | 4.79 | |
| Avg | 3.49 | 3.74 | 4.15 | |
| Low | 3.28 | 3.10 | 3.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 26.2% | 27.9% | |
| Avg | - | 7.4% | 10.9% | |
| Low | - | -11.1% | -9.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.